A comprehensive overview of advanced dynamic in vitro intestinal and hepatic cell culture models

References

• Naidoo P, Bouharati C, Rambiritch V, Jose N, Karamchand S, Chilton R, Leisegang R. Real-world evidence and product development: opportunities, challenges and risk mitigation. Wien Klin Wochenschr. 2021;9:13–47. doi:10.1007/s00508-021-01851-w.
   Google Scholar
• Mohs RC, Greig NH. Drug discovery and development: role of basic biological research. Alzheimer’s Dement Transl Res Clin Interv. 2017;3(4):651–657. doi:10.1016/j.trci.2017.10.005.
   PubMedGoogle Scholar
• Seyhan AA. Lost in translation: the Valley of death across preclinical and clinical divide – identification of problems and overcoming obstacles. Transl Med Commun. 2019;4(1):18. doi:10.1186/S41231-019-0050-7.
   Google Scholar
• Wouters OJ, McKee M, Luyten J. Estimated research and development investment needed to bring a new medicine to market, 2009-2018. JAMA - J Am Med Assoc. 2020;323(9):844–853. doi:10.1001/jama.2020.1166.
   PubMed Web of Science ®Google Scholar
• Cousins RPC. Medicines discovery for auditory disorders: challenges for industry. J Acoust Soc Am. 2019;146(5):3652–3667. doi:10.1121/1.5132706.
   PubMed Web of Science ®Google Scholar
• Van Norman GA. Limitations of animal studies for predicting toxicity in clinical trials: is it time to rethink our current approach? JACC Basic to Transl Sci. 2019;4(7):845–854. doi:10.1016/j.jacbts.2019.10.008.
   PubMedGoogle Scholar
• Shuler ML. Organ-, body- and disease-on-a-chip systems. Lab Chip. 2017;17(14):2345–2346. doi:10.1039/C7LC90068F.
   PubMed Web of Science ®Google Scholar
• Directive 2010/63/EU of the European parliament and of the Council of 22 September 2010 on the protection of animals used for scientific purposes . Official Journal of the European Union. October 20, 2010:33–79.
   Google Scholar
• Zuang V, Dura A, Worth A, David AB, Sofia BL, Elisabet BE, Stephanie BO, Donatella CA, Silvia CA, Sandra CO, Raffaella CO, Pierre DE. Non-animal methods in science and regulation-EURL ECVAM status report (2020. EUR 30553 EN. 2021. doi:10.2760/719755.
   Google Scholar
• Homayun B, Lin X, Choi HJ. Challenges and recent progress in oral drug delivery systems for biopharmaceuticals. Pharmaceutics. 2019;11(3):129. doi:10.3390/pharmaceutics11030129.
   PubMed Web of Science ®Google Scholar
• Hugenholtz F, de Vos WM. Mouse models for human intestinal microbiota research: a critical evaluation. Cell Mol Life Sci. 2018;75(1):149–160. doi:10.1007/S00018-017-2693-8.
   PubMed Web of Science ®Google Scholar
• Jung SM, Kim S. In vitro models of the small intestine for studying intestinal diseases. Front Microbiol. 2022;12:767038. doi:10.3389/FMICB.2021.767038/BIBTEX.
   PubMed Web of Science ®Google Scholar
• Hua S. Advances in oral drug delivery for regional targeting in the gastrointestinal tract - influence of physiological, pathophysiological and pharmaceutical factors. Front Pharmacol. 2020;11:524. doi:10.3389/fphar.2020.00524.
   PubMed Web of Science ®Google Scholar
• Avvari RK. Biomechanics of the small intestinal contractions. In: Qi X, Koruth S, editors. Digestive system - recent advances. 1st. IntechOpen; 2019. p. 1–25. doi:10.5772/INTECHOPEN.86539.
   Google Scholar
• Izumi K, Kato H, Feinberg SE. Tissue engineered oral Mucosa. In: Vishwakarma A, Sharpe P, Shi S, Ramalingam M, editors. Stem cell biology and tissue engineering in dental sciences. Vol 1. 1st. Elsevier Inc.; 2015. p. 721–731. doi:10.1016/B978-0-12-397157-9.00077-1.
   Google Scholar
• Collins SD, Yuen G, Tu T. In vitro models of the liver: disease modeling, drug discovery and clinical applications. Tirnitz-Parker JEE, editor. Hepatocellular Carcinoma. 1st. Codon Publications; 2019. 47–67. 10.15586/hepatocellularcarcinoma.2019.ch3.
   Google Scholar
• Lee SA, No DY, Kang E, Ju J, Kim DS, Lee SH. Spheroid-based three-dimensional liver-on-a-chip to investigate hepatocyte-hepatic stellate cell interactions and flow effects. Lab Chip. 2013;13(18):3529–3537. doi:10.1039/c3lc50197c.
   PubMed Web of Science ®Google Scholar
• Tennant BC, Center SA. Hepatic Function. In: Kaneko J, Harvey J, Bruss M, editors. Clinical biochemistry of domestic animals. Vol 1. 6th. Elsevier Inc.; 2008. p. 379–412. doi:10.1016/B978-0-12-370491-7.00013-1.
   Google Scholar
• Clevers H. The intestinal crypt, a prototype stem cell compartment. Cell Press. 2013;154(2):274–284. doi:10.1016/j.cell.2013.07.004.
   Google Scholar
• Furuya S, Furuya K. Roles of substance P and ATP in the subepithelial fibroblasts of rat intestinal villi. G HB, J FD, K WJ, Friedlander M, Jarvik J, editors. International review of cell and molecular biology. Vol. 304. 1st. Elsevier Inc.; 2013. 133–189. 10.1016/B978-0-12-407696-9.00003-8
   Google Scholar
• Lange K. Fundamental role of microvilli in the main functions of differentiated cells: outline of an universal regulating and signaling system at the cell periphery. J Cell Physiol. 2011;226(4):896–927. doi:10.1002/jcp.22302.
   PubMed Web of Science ®Google Scholar
• Sicard JF, Bihan G, Le, Vogeleer P, Jacques M, Harel J. Interactions of intestinal bacteria with components of the intestinal mucus. Front Cell Infect Microbiol. 2017;7:387. doi:10.3389/fcimb.2017.00387.
   PubMed Web of Science ®Google Scholar
• X-G L, Chen M, Zhao S, Wang X. Intestinal models for personalized medicine: from conventional models to microfluidic primary intestine-on-a-chip. Stem Cell Rev Reports. 2022;18(6):2137–2151. doi:10.1007/S12015-021-10205-Y.
   PubMed Web of Science ®Google Scholar
• Aguilar-Rojas A, Olivo-Marin J-C, Guillen N. Human intestinal models to study interactions between intestine and microbes. Open Biol. 2020;10(10):200199. doi:10.1098/RSOB.200199.
   PubMed Web of Science ®Google Scholar
• Sekiguchi R, Yamada KM. Basement Membranes in Development and Disease. Curr Top Dev Biol. 2018;130:143–191. doi:10.1016/BS.CTDB.2018.02.005.
   PubMed Web of Science ®Google Scholar
• Moradi E, Jalili-Firoozinezhad S, Solati-Hashjin M. Microfluidic organ-on-a-chip models of human liver tissue. Acta Biomater. 2020;116:67–83. doi:10.1016/J.ACTBIO.2020.08.041.
   PubMed Web of Science ®Google Scholar
• Kmiec Z. Cooperation of liver cells in health and disease. Vol 161.1st,Beck F, Christ B, Kriz W, et al.eds. Springer-Verlag;Berlin Heidelberg;2001.10.1007/978-3-642-56553-3.
   Google Scholar
• Török G, Erdei Z, Lilienberg J, Apáti Á, Homolya L, Laconi E. The importance of transporters and cell polarization for the evaluation of human stem cell-derived hepatic cells. PLoS One. 2020;15(1):e0227751. doi:10.1371/journal.pone.0227751.
   PubMed Web of Science ®Google Scholar
• Llewellyn SV, Niemeijer M, Nymark P, Moné MJ, van de Water B, Conway GE, Jenkins GJS, Doak SH. In vitro three-dimensional liver models for nanomaterial DNA damage assessment. Small . 2021;17(15):2006055. doi:10.1002/SMLL.202006055.
   Web of Science ®Google Scholar
• Ho CT, Lin RZ, Chen RJ, Chin C-K, Gong S-E, Chang H-Y, Peng H-L, Hsu L, Yew T-R, Chang S-F, et al. Liver-cell patterning lab chip: mimicking the morphology of liver lobule tissue. Lab Chip. 2013;13(18):3578–3587. doi:10.1039/c3lc50402f.
   PubMed Web of Science ®Google Scholar
• Lee SW, Jung DJ, Jeong GS. Gaining new biological and therapeutic applications into the liver with 3D in vitro liver models. Tissue Eng Regen Med. 2020;17(6):731–745. doi:10.1007/s13770-020-00245-9.
   PubMed Web of Science ®Google Scholar
• Kimura H, Sakai Y, Fujii T. Organ/body-on-a-chip based on microfluidic technology for drug discovery. Drug Metab Pharmacokinet. 2018;33(1):43–48. doi:10.1016/j.dmpk.2017.11.003.
   PubMed Web of Science ®Google Scholar
• Zhang S, Chen W, Zhu C. Liver Structure. In: Li L, editor. Artificial Liver. 1st. Springer Singapore; 2021. p. 21–47. doi:10.1007/978-981-15-5984-6_2.
   Google Scholar
• Agarwal T, Subramanian B, Maiti TK. Liver tissue engineering: challenges and opportunities. ACS Biomater Sci Eng. 2019;5(9):4167–4182. doi:10.1021/acsbiomaterials.9b00745.
   PubMed Web of Science ®Google Scholar
• Saji Joseph J, Tebogo Malindisa S, Ntwasa M. Two-dimensional (2D) and three-dimensional (3D) cell culturing in drug discovery. In: Mehanna RA, editor. Cell Culture. 1st. IntechOpen; 2019. p. 21–42. doi:10.5772/intechopen.81552.
   Google Scholar
• Kapałczyńska M, Kolenda T, Przybyła W, Zajączkowska M, Teresiak A, Filas V, Ibbs M, Bliźniak R, Łuczewski Ł, Lamperska K, et al. 2D and 3D cell cultures – a comparison of different types of cancer cell cultures. Arch Med Sci. 2018;14(4):910–919. doi:10.5114/aoms.2016.63743.
   PubMed Web of Science ®Google Scholar
• Huang RL, Liu K, Li Q. Bone regeneration following the in vivo bioreactor principle: is in vitro manipulation of exogenous elements still needed? Regen Med. 2016;11(5):475–481. doi:10.2217/RME-2016-0021.
   PubMed Web of Science ®Google Scholar
• Lee PJ, Gaige TA, Hung PJ. Dynamic cell culture: a microfluidic function generator for live cell microscopy. Lab Chip. 2009;9(1):164–166. doi:10.1039/b807682k.
   PubMed Web of Science ®Google Scholar
• Clementi A, Egger D, Charwat V, Kasper C. Cell culture conditions: cultivation of stem cells under dynamic conditions. In: J MG, Marolt Presen D, Oreffo R, Redl H, Wolbank S, editors. Cell engineering and regeneration. 1st. Springer International Publishing; 2018. p. 1–33. doi:10.1007/978-3-319-37076-7_58-1.
   Google Scholar
• Frey LJ, Krull R. Microbioreactors for process development and cell-based screening studies. In: Bahnemann J, Grünberger A, editors. Microfluidics in biotechnology. Advances in biochemical engineering/biotechnology. Cham: Springer; 2020. p. 67–100. doi:10.1007/10_2020_130.
   Google Scholar
• Grün C, Altmann B, Gottwald E. Advanced 3D cell culture techniques in micro-bioreactors, Part I: a systematic analysis of the literature published between 2000 and 2020. Processes. 2020;8(12):1656. doi:10.3390/PR8121656.
   Web of Science ®Google Scholar
• Altmann B, Grün C, Nies C, Gottwald E. Advanced 3D cell culture techniques in micro-bioreactors, Part II: systems and applications. Processes. 2020;9(1):21. doi:10.3390/PR9010021.
   Web of Science ®Google Scholar
• Freed LE, Guilak F. Engineering functional tissues. In: Lanza R, Langer R, Vacanti J, editors. Principles of Tissue Engineering. 3rd. Academic Press; 2007. p. 137–153. doi:10.1016/B978-012370615-7/50015-9.
   Google Scholar
• Singh M, Kasper FK, Mikos AG. Tissue engineering scaffolds. In: Ratner BD, Hoffman AS, Schoen FJ, Lemons JE, editors. Biomaterials science: an introduction to materials: third edition. II.6.3. Academic Press;2013. p. 1138–1159. doi:10.1016/B978-0-08-087780-8.00110-8.
   Google Scholar
• Barrila J, Radtke AL, Crabbé A, Sarker SF, Herbst-Kralovetz MM, Ott CM, Nickerson CA. Organotypic 3D cell culture models: using the rotating wall vessel to study host-pathogen interactions. Nat Rev Microbiol. 2010;8(11):791–801. doi:10.1038/NRMICRO2423.
   PubMed Web of Science ®Google Scholar
• Mehrian M, Lambrechts T, Papantoniou I, Geris L. Computational modeling of human mesenchymal stromal cell proliferation and extra-cellular matrix production in 3D porous scaffolds in a perfusion bioreactor: the effect of growth factors. Front Bioeng Biotechnol. 2020;8:376. doi:10.3389/fbioe.2020.00376.
   PubMed Web of Science ®Google Scholar
• Nankervis B, Jones M, Vang B, Brent Rice R, Coeshott C, Beltzer J. Optimizing T cell expansion in a hollow-fiber bioreactor. Curr Stem Cell Reports. 2018;4(1):46–51. doi:10.1007/S40778-018-0116-X.
   PubMed Web of Science ®Google Scholar
• Storm MP, Sorrell I, Shipley R, Regan S, Luetchford KA, Sathish J, Webb S, Ellis MJ. Hollow fiber bioreactors for in vivo-like mammalian tissue culture. J Vis Exp. 2016;2016(111):53431. doi:10.3791/53431.
   Google Scholar
• Stephenson M, Grayson W. Recent advances in bioreactors for cell-based therapies. F1000Research. 2018;7:517. doi:10.12688/f1000research.12533.1.
   Google Scholar
• Lee PJ, Hung PJ, Lee LP. An artificial liver sinusoid with a microfluidic endothelial-like barrier for primary hepatocyte culture. Biotechnol Bioeng. 2007;97(5):1340–1346. doi:10.1002/bit.21360.
   PubMed Web of Science ®Google Scholar
• van den BA, Mummery CL, Passier R, van der MAD. Personalised organs-on-chips: functional testing for precision medicine. Lab Chip. 2019;19(2):198–205. doi:10.1039/C8LC00827B.
   PubMed Web of Science ®Google Scholar
• Mandenius CF. Conceptual design of micro-bioreactors and organ-on-chips for studies of cell cultures. Bioengineering. 2018;5(3):56. doi:10.3390/bioengineering5030056.
   PubMedGoogle Scholar
• Jensen C, Teng Y. Is it time to start transitioning from 2D to 3D cell culture? Front Mol Biosci. 2020;7:33. doi:10.3389/fmolb.2020.00033.
   PubMed Web of Science ®Google Scholar
• Wu X, Su J, Wei J, Jiang N, Ge X, Dias Da Silva VJ. Recent advances in three-dimensional stem cell culture systems and applications. Stem Cells Int. 2021;2021:9477332. doi:10.1155/2021/9477332.
   PubMed Web of Science ®Google Scholar
• Terrell JA, Jones CG, Keza G, Kabandana M, Chen C. From cells-on-a-chip to organs-on-a-chip: scaffolding materials for 3D cell culture in microfluidics. J Mater Chem B. 2020;8:6667–6685. doi:10.1039/d0tb00718h.
   PubMed Web of Science ®Google Scholar
• Jun I, Han HS, Edwards JR, Jeon H. Electrospun fibrous scaffolds for tissue engineering: viewpoints on architecture and fabrication. Int J Mol Sci. 2018;19(3):745. doi:10.3390/IJMS19030745.
   PubMed Web of Science ®Google Scholar
• Grassart A, Malardé V, Gobba S, Sartori-Rupp A, Kerns J, Karalis K, Marteyn B, Sansonetti P, Sauvonnet N. Bioengineered human organ-on-chip reveals intestinal microenvironment and mechanical forces impacting shigella infection. Cell Host Microbe. 2019;26(3):435–444. doi:10.1016/j.chom.2019.08.007.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Ingber DE. Gut-on-a-Chip microenvironment induces human intestinal cells to undergo villus differentiation. Integr Biol (United Kingdom). 2013;5(9):1130–1140. doi:10.1039/c3ib40126j.
   PubMed Web of Science ®Google Scholar
• Trietsch SJ, Naumovska E, Kurek D, Setyawati MC, Vormann MK, Wilschut KJ, Lanz HL, Nicolas A, Ng CP, Joore J, Kustermann S. Membrane-free culture and real-time barrier integrity assessment of perfused intestinal epithelium tubes. Nat Commun. 2017;8(1):262. doi:10.1038/s41467-017-00259-3.
   PubMedGoogle Scholar
• Lee SY, Kim D, Lee SH, Sung JH. Microtechnology-based in vitro models: mimicking liver function and pathophysiology. APL Bioeng. 2021;5(4):041505. doi:10.1063/5.0061896.
   PubMed Web of Science ®Google Scholar
• Fedi A, Vitale C, Ponschin G, Ayehunie S, Fato M, Scaglione S. In vitro models replicating the human intestinal epithelium for absorption and metabolism studies: a systematic review. J Control Release. 2021;335:247–268. doi:10.1016/J.JCONREL.2021.05.028.
   PubMed Web of Science ®Google Scholar
• Temple J, Velliou E, Shehata M, Lévy R. Current strategies with implementation of three-dimensional cell culture: the challenge of quantification. Interface Focus. 2022;12(5):20220019. doi:10.1098/RSFS.2022.0019.
   PubMed Web of Science ®Google Scholar
• Alblawi A, Ranjani AS, Yasmin H, Gupta S, Bit A, Rahimi-Gorji M. Scaffold-free: a developing technique in field of tissue engineering. Comput Methods Programs Biomed. 2020;185:105148. doi:10.1016/J.CMPB.2019.105148.
   PubMed Web of Science ®Google Scholar
• Hynds RE, Giangreco A. The relevance of human stem cell-derived organoid models for epithelial translational medicine. Stem Cells. 2013;31(3):417–422. doi:10.1002/stem.1290.
   PubMed Web of Science ®Google Scholar
• Fang Y, Eglen RM. Three-dimensional cell cultures in drug discovery and development. SLAS Discov. 2017;22(5):456–472. doi:10.1177/1087057117696795.
   PubMed Web of Science ®Google Scholar
• Moschouris K, Firoozi N, Kang Y. The application of cell sheet engineering in the vascularization of tissue regeneration. Regen Med. 2016;11(6):559–570. doi:10.2217/RME-2016-0059.
   PubMed Web of Science ®Google Scholar
• Yang J, Zhao S, Ji Y, Zhao L, Kong Q, Zhang Q. Cell sheet-based multilayered liver tumor models for anti-cancer drug screening. Biotechnol Lett. 2017;40(2):427–435. doi:10.1007/S10529-017-2476-1.
   PubMed Web of Science ®Google Scholar
• Bein A, Shin W, Jalili-Firoozinezhad S, Park MH, Sontheimer-Phelps A, Tovaglieri A, Chalkiadaki A, Kim HJ, Ingber DE. Microfluidic organ-on-a-chip models of human intestine. Cell Mol Gastroenterol Hepatol. 2018;5(4):659–668. doi:10.1016/J.JCMGH.2017.12.010.
   PubMed Web of Science ®Google Scholar
• Raghavan S, Mehta P, Horst EN, Ward MR, Rowley KR, Mehta G. Comparative analysis of tumor spheroid generation techniques for differential in vitro drug toxicity. Oncotarget. 2016;7(13):16948–16961. doi:10.18632/ONCOTARGET.7659.
   PubMedGoogle Scholar
• Annunziato S, Tchorz JS. Liver zonation—a journey through space and time. Nat Metab. 2021;3(1):7–8. doi:10.1038/s42255-020-00333-z.
   PubMedGoogle Scholar
• Garcia-Cortes M, Robles-Diaz M, Stephens C, Ortega-Alonso A, Lucena MI, Andrade RJ. Drug induced liver injury: an update. Arch Toxicol. 2020;94(10):3381–3407. doi:10.1007/s00204-020-02885-1.
   PubMed Web of Science ®Google Scholar
• Minerali E, Foil DH, Zorn KM, Lane TR, Ekins S. Comparing machine learning algorithms for predicting drug-induced liver injury (Dili). Mol Pharm. 2020;17(7):2628–2637. doi:10.1021/acs.molpharmaceut.0c00326.
   PubMed Web of Science ®Google Scholar
• Zeilinger K, Freyer N, Damm G, Seehofer D, Knöspel F. Cell sources for in vitro human liver cell culture models. Exp Biol Med. 2016;241(15):1684–1698. doi:10.1177/1535370216657448.
   PubMed Web of Science ®Google Scholar
• Mahler GJ, Shuler ML, Glahn RP. Characterization of Caco-2 and HT29-MTX cocultures in an in vitro digestion/cell culture model used to predict iron bioavailability. J Nutr Biochem. 2009;20(7):494–502. doi:10.1016/J.JNUTBIO.2008.05.006.
   PubMed Web of Science ®Google Scholar
• Costa J, Ahluwalia A. Advances and current challenges in intestinal in vitro model engineering: a digest. Front Bioeng Biotechnol. 2019;7:144. doi:10.3389/fbioe.2019.00144.
   PubMed Web of Science ®Google Scholar
• Lu Y, Qi J, Wu W. Lipid nanoparticles: in vitro and in vivo approaches in drug delivery and targeting. Grumezescu AM, editor. Drug targeting and stimuli sensitive drug delivery systems. 1st. William Andrew Publishing; 2018. 749–783. 10.1016/B978-0-12-813689-8.00020-3.
   Google Scholar
• Sonia TA, Sharma CP. Experimental techniques involved in the development of oral insulin carriers. Oral delivery of insulin.1st.Woodhead Publishing;2014.169–217.10.1533/9781908818683.169.
   Google Scholar
• Hidalgo IJ, Raub TJ, Borchardt RT. Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology. 1989;96(3):736–749. doi:10.1208/s12248-011-9283-8.
   PubMed Web of Science ®Google Scholar
• Hilgers AR, Conradi RA, Burton PS. Caco-2 cell monolayers as a model for drug transport across the intestinal mucosa. Pharm Res. 1990;7(9):902–910. doi:10.1023/A:1015937605100.
   PubMed Web of Science ®Google Scholar
• Hoffmann P, Burmester M, Langeheine M, Brehm R, Empl MT, Seeger B, Breves G. Caco-2/HT29-MTX co-cultured cells as a model for studying physiological properties and toxin-induced effects on intestinal cells. PLoS One. 2021;16(10):e0257824. doi:10.1371/JOURNAL.PONE.0257824.
   PubMed Web of Science ®Google Scholar
• Gagnon M, Zihler Berner A, Chervet N, Chassard C, Lacroix C. Comparison of the Caco-2, HT-29 and the mucus-secreting HT29-MTX intestinal cell models to investigate Salmonella adhesion and invasion. J Microbiol Methods. 2013;94(3):274–279. doi:10.1016/J.MIMET.2013.06.027.
   PubMed Web of Science ®Google Scholar
• Kleiveland CR. Co-cultivation of Caco-2 and HT-29MTX. Verhoeckx K, Cotter P, López-Expósito I, editors. The impact of food bioactives on health: in vitro and ex vivo models. 1st. Springer; 2015. 135–140. 10.1007/978-3-319-16104-4_13.
   Google Scholar
• Bhatia SN, Ingber DE. Microfluidic organs-on-chips. Nat Biotechnol . 2014;32(8):760–772. doi:10.1038/nbt.2989.
   PubMed Web of Science ®Google Scholar
• Maaser C, Schoeppner S, Kucharzik T, Kraft M, Schoenherr E, Domschke W, Luegering N. Colonic epithelial cells induce endothelial cell expression of ICAM-1 and VCAM-1 by a NF- κ B-dependent mechanism. Clin Exp Immunol. 2001;124(2):208–213. doi:10.1046/J.1365-2249.2001.01541.X.
   PubMed Web of Science ®Google Scholar
• Grootaert C, Kamiloglu S, Capanoglu E, Van Camp J. Cell systems to investigate the impact of polyphenols on cardiovascular health. Nutrients. 2015;7(11):9229–9255. doi:10.3390/NU7115462.
   PubMed Web of Science ®Google Scholar
• Butler M, Ng CY, van Heel DA, Lombardi G, Lechler R, Playford R, Ghosh S. Modulation of dendritic cell phenotype and function in an in vitro model of the intestinal epithelium. Eur J Immunol. 2006;36(4):864–874. doi:10.1002/EJI.200535497.
   PubMed Web of Science ®Google Scholar
• Parlesak A, Haller D, Brinz S, Baeuerlein A, Bode C. Modulation of cytokine release by differentiated CACO-2 cells in a compartmentalized coculture model with mononuclear leucocytes and nonpathogenic bacteria. Scand J Immunol. 2004;60(5):477–485. doi:10.1111/J.0300-9475.2004.01495.X.
   PubMed Web of Science ®Google Scholar
• Thuenauer R, Rodriguez-Boulan E, Rümer W. Microfluidic approaches for epithelial cell layer culture and characterisation. Analyst. 2014;139(13):3206–3218. doi:10.1039/C4AN00056K.
   PubMed Web of Science ®Google Scholar
• Jalili-Firoozinezhad S, Gazzaniga FS, Calamari EL, Camacho DM, Fadel CW, Bein A, Swenor B, Nestor B, Cronce MJ, Tovaglieri A, et al. A complex human gut microbiome cultured in an anaerobic intestine-on-a-chip. Nat Biomed Eng. 2019;3(7):520–531. doi:10.1038/s41551-019-0397-0.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Huh D, Hamilton G, Ingber DE. Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow. Lab Chip. 2012;12(12):2165–2174. doi:10.1039/c2lc40074j.
   PubMed Web of Science ®Google Scholar
• Pocock K, Delon L, Bala V, Rao S, Priest C, Prestidge C, Thierry B. Intestine-on-A-chip microfluidic model for efficient in vitro screening of oral chemotherapeutic uptake. ACS Biomater Sci Eng. 2017;3(6):951–959. doi:10.1021/acsbiomaterials.7b00023.
   PubMed Web of Science ®Google Scholar
• Shim KY, Lee D, Han J, Nguyen NT, Park S, Sung JH. Microfluidic gut-on-a-chip with three-dimensional villi structure. Biomed Microdevices. 2017;19(2):37. doi:10.1007/s10544-017-0179-y.
   PubMed Web of Science ®Google Scholar
• Chi M, Yi B, Oh S, Park DJ, Sung JH, Park S. A microfluidic cell culture device (μFCCD) to culture epithelial cells with physiological and morphological properties that mimic those of the human intestine. Biomed Microdevices. 2015;17(3):9966. doi:10.1007/s10544-015-9966-5.
   PubMed Web of Science ®Google Scholar
• De Gregorio V, Corrado B, Sbrescia S, Sibilio S, Urciuolo F, Netti PA, Imparato G. Intestine-on-chip device increases ECM remodeling inducing faster epithelial cell differentiation. Biotechnol Bioeng. 2020;117(2):556–566. doi:10.1002/bit.27186.
   PubMed Web of Science ®Google Scholar
• Gumuscu B, Albers HJ, Van Den Berg A, Eijkel JCT, Van Der Meer AD. Compartmentalized 3D tissue culture arrays under controlled microfluidic delivery. Sci Rep. 2017;7(1):3381. doi:10.1038/s41598-017-01944-5.
   PubMedGoogle Scholar
• Marzorati M, Vanhoecke B, De Ryck T, Sadaghian Sadabad M, Pinheiro I, Possemiers S, Van den Abbeele P, Derycke L, Bracke M, Pieters J, et al. The HMITM module: a new tool to study the host-microbiota interaction in the human gastrointestinal tract in vitro. BMC Microbiol. 2014;14(1):133. doi:10.1186/1471-2180-14-133.
   PubMedGoogle Scholar
• Maurer M, Gresnigt MS, Last A, Wollny T, Berlinghof F, Pospich R, Cseresnyes Z, Medyukhina A, Graf K, Gröger M, et al. A three-dimensional immunocompetent intestine-on-chip model as in vitro platform for functional and microbial interaction studies. Biomaterials. 2019;220:119396. doi:10.1016/j.biomaterials.2019.119396.
   PubMed Web of Science ®Google Scholar
• Shah P, Fritz JV, Glaab E, Desai MS, Greenhalgh K, Frachet A, Niegowska M, Estes M, Jäger C, Seguin-Devaux C, et al. A microfluidics-based in vitro model of the gastrointestinal human-microbe interface. Nat Commun. 2016;7(1):11535. doi:10.1038/ncomms11535.
   PubMedGoogle Scholar
• Kasendra M, Tovaglieri A, Sontheimer-Phelps A, Jalili-Firoozinezhad S, Bein A, Chalkiadaki A, Scholl W, Zhang C, Rickner H, Richmond CA, et al. Development of a primary human small intestine-on-a-chip using biopsy-derived organoids. Sci Rep. 2018;8(1):2871. doi:10.1038/s41598-018-21201-7.
   PubMed Web of Science ®Google Scholar
• Smith ME, Morton DG. THE SMALL INTESTINE. In: Horne T, Stader L, editors. The digestive system. Vol 1. 2nd. Elsevier; 2010. p. 107–127. doi:10.1016/B978-0-7020-3367-4.00007-4.
   Google Scholar
• Imura Y, Asano Y, Sato K, Yoshimura E. A microfluidic system to evaluate intestinal absorption. Anal Sci. 2009;25(12):1403–1407. doi:10.2116/analsci.25.1403.
   PubMed Web of Science ®Google Scholar
• Chang SY, Voellinger JL, Van Ness KP, Chapron B, Shaffer RM, Neumann T, White CC, Kavanagh TJ, Kelly EJ, Eaton DL, et al. Characterization of rat or human hepatocytes cultured in microphysiological systems (MPS) to identify hepatotoxicity. Toxicol Vitr. 2017;40:170–183. doi:10.1016/j.tiv.2017.01.007.
   PubMed Web of Science ®Google Scholar
• Mondrinos MJ, Yi YS, Wu NK, Ding X, Huh D. Native extracellular matrix-derived semipermeable, optically transparent, and inexpensive membrane inserts for microfluidic cell culture. Lab Chip. 2017;17(18):3146–3158. doi:10.1039/c7lc00317j.
   PubMed Web of Science ®Google Scholar
• Zheng D, Liwinski T, Elinav E. Interaction between microbiota and immunity in health and disease. Cell Res. 2020;30(6):492–506. doi:10.1038/s41422-020-0332-7.
   PubMed Web of Science ®Google Scholar
• Shreiner AB, Kao JY, Young VB. The gut microbiome in health and in disease. Curr Opin Gastroenterol. 2015;31(1):69–75. doi:10.1097/MOG.0000000000000139.
   PubMed Web of Science ®Google Scholar
• Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell. 2012;148(6):1258–1270. doi:10.1016/j.cell.2012.01.035.
   PubMed Web of Science ®Google Scholar
• Lim W, Park S. A microfluidic spheroid culture device with a concentration gradient generator for high-throughput screening of drug efficacy. Mol . 2018;23(12):3355. doi:10.3390/MOLECULES23123355.
   PubMed Web of Science ®Google Scholar
• Ayuso JM, Virumbrales-Muñoz M, Lacueva A, Lanuza PM, Checa-Chavarria E, Botella P, Fernández E, Doblare M, Allison SJ, Phillips RM, et al. Development and characterization of a microfluidic model of the tumour microenvironment. Sci Rep. 2016;6(1):36086. doi:10.1038/srep36086.
   PubMedGoogle Scholar
• Toley BJ, Tropeano Lovatt ZG, Harrington JL, Forbes NS. Microfluidic technique to measure intratumoral transport and calculate drug efficacy shows that binding is essential for doxorubicin and release hampers Doxil. Integr Biol (Camb). 2013;5(9):1184–1196. doi:10.1039/C3IB40021B.
   PubMed Web of Science ®Google Scholar
• Donato MT, Tolosa L, Gómez-Lechón MJ. Culture and functional characterization of human hepatoma HepG2 Cells. Methods Mol Biol . 2015;1250:77–93. doi:10.1007/978-1-4939-2074-7_5.
   PubMedGoogle Scholar
• Arzumanian VA, Kiseleva OI, Poverennaya EV. The curious case of the HepG2 cell line: 40 years of expertise. Int J Mol Sci. 2021;22(23):13135. doi:10.3390/IJMS222313135.
   PubMed Web of Science ®Google Scholar
• Gupta K, Song Z, Tang H, Fong ELS, Ng IC, Yu H. Liver tissue engineering. In: Ducheyne P, editor. Comprehensive biomaterials II. Vol 6. 1st. Elsevier; 2017. p. 491–512. doi:10.1016/B978-0-12-803581-8.10163-8.
   Google Scholar
• Große-Segerath L, Lammert E. Role of vasodilation in liver regeneration and health. Biol Chem. 2021;402(9):1009–1019. doi:10.1515/HSZ-2021-0155/ASSET/GRAPHIC/J_HSZ-2021-0155_FIG_003.JPG.
   PubMed Web of Science ®Google Scholar
• Kang YBA, Sodunke TR, Lamontagne J, Cirillo J, Rajiv C, Bouchard MJ, Noh M. Liver sinusoid on a chip: long-term layered co-culture of primary rat hepatocytes and endothelial cells in microfluidic platforms. Biotechnol Bioeng. 2015;112(12):2571–2582. doi:10.1002/bit.25659.
   PubMed Web of Science ®Google Scholar
• Yajima Y, Lee CN, Yamada M, Utoh R, Seki M. Development of a perfusable 3D liver cell cultivation system via bundling-up assembly of cell-laden microfibers. J Biosci Bioeng. 2018;126(1):111–118. doi:10.1016/j.jbiosc.2018.01.022.
   PubMed Web of Science ®Google Scholar
• Prodanov L, Jindal R, Bale SS, Hegde M, McCarty WJ, Golberg I, Bhushan A, Yarmush ML, Usta OB. Long-term maintenance of a microfluidic 3D human liver sinusoid. Biotechnol Bioeng. 2016;113(1):241–246. doi:10.1002/bit.25700.
   PubMed Web of Science ®Google Scholar
• Lee-Montiel FT, George SM, Gough AH, Sharma AD, Wu J, DeBiasio R, Vernetti LA, Taylor DL. Control of oxygen tension recapitulates zone-specific functions in human liver microphysiology systems. Exp Biol Med. 2017;242(16):1617–1632. doi:10.1177/1535370217703978.
   Web of Science ®Google Scholar
• Vernetti LA, Senutovitch N, Boltz R, DeBiasio R, Ying Shun T, Gough A, Taylor DL. A human liver microphysiology platform for investigating physiology, drug safety, and disease models. Exp Biol Med. 2016;241(1):101–114. doi:10.1177/1535370215592121.
   PubMed Web of Science ®Google Scholar
• Deng J, Zhang X, Chen Z, Luo Y, Lu Y, Liu T, Wu Z, Jin Y, Zhao W, Lin B, et al. A cell lines derived microfluidic liver model for investigation of hepatotoxicity induced by drug-drug interaction. Biomicrofluidics. 2019;13(2):024101. doi:10.1063/1.5070088.
   PubMed Web of Science ®Google Scholar
• Rennert K, Steinborn S, Gröger M, Ungerböck B, Jank A-M, Ehgartner J, Nietzsche S, Dinger J, Kiehntopf M, Funke H, et al. A microfluidically perfused three dimensional human liver model. Biomaterials. 2015;71:119–131. doi:10.1016/j.biomaterials.2015.08.043.
   PubMed Web of Science ®Google Scholar
• Jin M, Yi X, Liao W, Chen Q, Yang W, Li Y, Li S, Gao Y, Peng Q, Zhou S, et al. Advancements in stem cell-derived hepatocyte-like cell models for hepatotoxicity testing. Stem Cell Res Ther. 2021;12(1):84. doi:10.1186/S13287-021-02152-9.
   PubMed Web of Science ®Google Scholar
• Shih MC, Tseng SH, Weng YS, Chu IM, Liu CH. A microfluidic device mimicking acinar concentration gradients across the liver acinus. Biomed Microdevices. 2013;15(5):767–780. doi:10.1007/s10544-013-9762-z.
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang H, Deng P, Chen W, Guo Y, Tao T, Qin J. In situ differentiation and generation of functional liver organoids from human iPSCs in a 3D perfusable chip system. Lab Chip. 2018;18(23):3606–3616. doi:10.1039/c8lc00869h.
   PubMed Web of Science ®Google Scholar
• Allen JW, Bhatia SN. Formation of steady-state oxygen gradients in vitro: application to liver zonation. Biotechnol Bioeng. 2003;82(3):253–262. doi:10.1002/bit.10569.
   PubMed Web of Science ®Google Scholar
• Zhu L, Xia H, Wang Z, Fong ELS, Fan J, Tong WH, Seah YPD, Zhang W, Li Q, Yu H, et al. A vertical-flow bioreactor array compacts hepatocytes for enhanced polarity and functions. Lab Chip. 2016;16(20):3898–3908. doi:10.1039/c6lc00811a.
   PubMed Web of Science ®Google Scholar
• McCarty WJ, Usta OB, Yarmush ML. A microfabricated platform for generating physiologically-relevant hepatocyte zonation. Sci Rep. 2016;6(1):26868. doi:10.1038/srep26868.
   PubMedGoogle Scholar
• Nakao Y, Kimura H, Sakai Y, Fujii T. Bile canaliculi formation by aligning rat primary hepatocytes in a microfluidic device. Biomicrofluidics. 2011;5(2):022212. doi:10.1063/1.3580753.
   PubMed Web of Science ®Google Scholar
• Kang YBA, Eo J, Mert S, Yarmush ML, Usta OB. Metabolic patterning on a chip: towards in vitro liver zonation of primary rat and human hepatocytes. Sci Rep. 2018;8(1):8951. doi:10.1038/s41598-018-27179-6.
   PubMedGoogle Scholar
• Carraro A, Hsu WM, Kulig KM, Cheung WS, Miller ML, Weinberg EJ, Swart EF, Kaazempur-Mofrad M, Borenstein JT, Vacanti JP, et al. In vitro analysis of a hepatic device with intrinsic microvascular-based channels. Biomed Microdevices. 2008;10(6):795–805. doi:10.1007/s10544-008-9194-3.
   PubMed Web of Science ®Google Scholar
• Banaeiyan AA, Theobald J, Paukštyte J, Wölfl S, Adiels CB, Goksör M. Design and fabrication of a scalable liver-lobule-on-a-chip microphysiological platform. Biofabrication. 2017;9(1):015014. doi:10.1088/1758-5090/9/1/015014.
   PubMed Web of Science ®Google Scholar
• Chao P, Maguire T, Novik E, Cheng KC, Yarmush ML. Evaluation of a microfluidic based cell culture platform with primary human hepatocytes for the prediction of hepatic clearance in human. Biochem Pharmacol. 2009;78(6):625–632. doi:10.1016/j.bcp.2009.05.013.
   PubMed Web of Science ®Google Scholar
• Allen JW, Khetani SR, Bhatia SN. In vitro zonation and toxicity in a hepatocyte bioreactor. Toxicol Sci. 2005;84(1):110–119. doi:10.1093/toxsci/kfi052.
   PubMed Web of Science ®Google Scholar
• Du Y, Li N, Yang H, Luo C, Gong Y, Tong C, Gao Y, Lü S, Long M. Mimicking liver sinusoidal structures and functions using a 3D-configured microfluidic chip. Lab Chip. 2017;17(5):782–794. doi:10.1039/c6lc01374k.
   PubMed Web of Science ®Google Scholar
• Jang KJ, Otieno MA, Ronxhi J, Lim H-K, Ewart L, Kodella KR, Petropolis DB, Kulkarni G, Rubins JE, Conegliano D, et al. Reproducing human and cross-species drug toxicities using a Liver-Chip. Sci Transl Med. 2019;11(517):eaax5516. doi:10.1126/scitranslmed.aax5516.
   PubMed Web of Science ®Google Scholar
• Sarkar U, Ravindra KC, Large E, Young CL, Rivera-Burgos D, Yu J, Cirit M, Hughes DJ, Wishnok JS, Lauffenburger DA, Griffith LG. Integrated assessment of diclofenac biotransformation, pharmacokinetics, and omics-based toxicity in a three-dimensional human liver-immunocompetent coculture systems. Drug Metab Dispos. 2017;45(7):855–866. doi:10.1124/dmd.116.074005.
   PubMed Web of Science ®Google Scholar
• Ma LD, Wang YT, Wang JR, Wu J-L, Meng X-S, Hu P, Mu X, Liang Q-L, Luo G-A. Design and fabrication of a liver-on-a-chip platform for convenient, highly efficient, and safe in situ perfusion culture of 3D hepatic spheroids. Lab Chip. 2018;18(17):2547–2562. doi:10.1039/c8lc00333e.
   PubMed Web of Science ®Google Scholar
• Jang M, Neuzil P, Volk T, Manz A, Kleber A. On-chip three-dimensional cell culture in phaseguides improves hepatocyte functions in vitro. Biomicrofluidics. 2015;9(3):034113. doi:10.1063/1.4922863.
   PubMed Web of Science ®Google Scholar
• Schepers A, Li C, Chhabra A, Seney BT, Bhatia S. Engineering a perfusable 3D human liver platform from iPS cells. Lab Chip. 2016;16(14):2644–2653. doi:10.1039/c6lc00598e.
   PubMed Web of Science ®Google Scholar
• Baudoin R, Prot JM, Nicolas G, Brocheton J, Brochot C, Legallais C, Benech H, Leclerc E. Evaluation of seven drug metabolisms and clearances by cryopreserved human primary hepatocytes cultivated in microfluidic biochips. Xenobiotica. 2013;43(2):140–152. doi:10.3109/00498254.2012.706725.
   PubMed Web of Science ®Google Scholar
• Baudoin R, Legendre A, Jacques S, Cotton J, Bois F, Leclerc E. Evaluation of a liver microfluidic biochip to predict in Vivo clearances of seven drugs in rats. J Pharm Sci. 2014;103(2):706–718. doi:10.1002/jps.23796.
   PubMed Web of Science ®Google Scholar
• Prot JM, Videau O, Brochot C, Legallais C, Bénech H, Leclerc E. A cocktail of metabolic probes demonstrates the relevance of primary human hepatocyte cultures in a microfluidic biochip for pharmaceutical drug screening. Int J Pharm. 2011;408(1–2):67–75. doi:10.1016/j.ijpharm.2011.01.054.
   PubMedGoogle Scholar
• Novik E, Maguire TJ, Chao P, Cheng KC, Yarmush ML. A microfluidic hepatic coculture platform for cell-based drug metabolism studies. Biochem Pharmacol. 2010;79(7):1036–1044. doi:10.1016/j.bcp.2009.11.010.
   PubMed Web of Science ®Google Scholar
• Toh YC, Lim TC, Tai D, Xiao G, Van Noort D, Yu H. A microfluidic 3D hepatocyte chip for drug toxicity testing. Lab Chip. 2009;9(14):2026–2035. doi:10.1039/b900912d.
   PubMed Web of Science ®Google Scholar
• Bircsak KM, DeBiasio R, Miedel M, Alsebahi A, Reddinger R, Saleh A, Shun T, Vernetti LA, Gough A. A 3D microfluidic liver model for high throughput compound toxicity screening in the OrganoPlate®. Toxicology. 2021;450:152667. doi:10.1016/j.tox.2020.152667.
   PubMed Web of Science ®Google Scholar
• Mi S, Yi X, Du Z, Xu Y, Sun W. Construction of a liver sinusoid based on the laminar flow on chip and self-assembly of endothelial cells. Biofabrication. 2018;10(2):025010. doi:10.1088/1758-5090/aaa97e.
   PubMed Web of Science ®Google Scholar
• Bhise NS, Manoharan V, Massa S, Tamayol A, Ghaderi M, Miscuglio M, Lang Q, Shrike Zhang Y, Shin SR, Calzone G, et al. A liver-on-a-chip platform with bioprinted hepatic spheroids. Biofabrication. 2016;8(1):014101. doi:10.1088/1758-5090/8/1/014101.
   PubMed Web of Science ®Google Scholar
• Yu F, Deng R, Hao Tong W, Huan L, Chan Way N, IslamBadhan A, Iliescu C, Yu H. A perfusion incubator liver chip for 3D cell culture with application on chronic hepatotoxicity testing. Sci Rep. 2017;7(1):14528. doi:10.1038/s41598-017-13848-5.
   PubMedGoogle Scholar
• Mazzei D, Guzzardi MA, Giusti S, Ahluwalia A. A low shear stress modular bioreactor for connected cell culture under high flow rates. Biotechnol Bioeng. 2010;106(1):127–137. doi:10.1002/bit.22671.
   PubMed Web of Science ®Google Scholar
• Hung PJ, Lee PJ, Sabounchi P, Aghdam N, Lin R, Lee LP. A novel high aspect ratio microfluidic design to provide a stable and uniform microenvironment for cell growth in a high throughput mammalian cell culture array. Lab Chip. 2005;5(1):44–48. doi:10.1039/b410743h.
   PubMed Web of Science ®Google Scholar
• Legendre A, Baudoin R, Alberto G, Paullier P, Naudot M, Bricks T, Brocheton J, Jacques S, Cotton J, Leclerc E, et al. Metabolic characterization of primary rat hepatocytes cultivated in parallel microfluidic biochips. J Pharm Sci. 2013;102(9):3264–3276. doi:10.1002/jps.23466.
   PubMed Web of Science ®Google Scholar
• Baudoin R, Griscom L, Prot JM, Legallais C, Leclerc E. Behavior of HepG2/C3A cell cultures in a microfluidic bioreactor. Biochem Eng J. 2011;53(2):172–181. doi:10.1016/j.bej.2010.10.007.
   Web of Science ®Google Scholar
• Meren H, Matsumura T, Kauffman FC, Thurman RG. Relationship between oxygen tension and oxygen uptake in the perfused rat liver. Adv Exp Med Biol. 1986;200:467–476. doi:10.1007/978-1-4684-5188-7_58.
   PubMedGoogle Scholar
• Matsumura T, Kauffman FC, Meren H, Thurman RG. O2 uptake in periportal and pericentral regions of liver lobule in perfused liver. Am J Physiol - Gastrointest Liver Physiol. 1986;250(6):G800–G805. doi:10.1152/ajpgi.1986.250.6.g800.
   Google Scholar
• Deng J, Wei W, Chen Z, Lin B, Zhao W, Luo Y, Zhang X. Engineered liver-on-a-chip platform to mimic liver functions and its biomedical applications: a review. Micromachines. 2019;10(10):676. doi:10.3390/mi10100676.
   PubMed Web of Science ®Google Scholar
• Dash A, Inman W, Hoffmaster K, Sevidal S, Kelly J, Obach RS, Griffith LG, Tannenbaum SR. Liver tissue engineering in the evaluation of drug safety. Expert Opin Drug Metab Toxicol. 2009;5:1159–1174.
   PubMed Web of Science ®Google Scholar
• Gebhardt R. Metabolic zonation of the liver: regulation and implications for liver function. Pharmacol Ther. 1992;53(3):275–354. doi:10.1016/0163-7258(92)90055-5.
   PubMed Web of Science ®Google Scholar
• Boyer JL. Bile formation and secretion. Compr Physiol. 2013;3(3):1035–1078. doi:10.1002/cphy.c120027.
   PubMed Web of Science ®Google Scholar
• Dash A, Simmers MB, Deering TG, Berry DJ, Feaver RE, Hastings NE, Pruett TL, LeCluyse EL, Blackman BR, Wamhoff BR, et al. Hemodynamic flow improves rat hepatocyte morphology, function, and metabolic activity in vitro. Am J Physiol - Cell Physiol. 2013;304(11):C1053–C1063. doi:10.1152/ajpcell.00331.2012.
   PubMed Web of Science ®Google Scholar
• Guo R, Xu X, Lu Y, Xie X. Physiological oxygen tension reduces hepatocyte dedifferentiation in in vitro culture. Sci Rep. 2017;7(1):5923. doi:10.1038/s41598-017-06433-3.
   PubMedGoogle Scholar
• Tostões RM, Leite SB, Serra M, Jensen J, Björquist P, Carrondo MJT, Brito C, Alves PM. Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing. Hepatology. 2012;55(4):1227–1236. doi:10.1002/hep.24760.
   PubMed Web of Science ®Google Scholar
• Esch MB, Ueno H, Applegate DR, Shuler ML. Modular, pumpless body-on-a-chip platform for the co-culture of GI tract epithelium and 3D primary liver tissue. Lab Chip. 2016;16(14):2719–2729. doi:10.1039/C6LC00461J.
   PubMed Web of Science ®Google Scholar
• Oleaga C, Bernabini C, Smith AST, Srinivasan B, Jackson M, McLamb W, Platt V, Bridges R, Cai Y, Santhanam N, et al. Multi-Organ toxicity demonstration in a functional human in vitro system composed of four organs. Sci Rep. 2016;6(1):20030. doi:10.1038/srep20030.
   PubMedGoogle Scholar
• Bovard D, Sandoz A, Luettich K, Frentzel S, Iskandar A, Marescotti D, Trivedi K, Guedj E, Dutertre Q, Peitsch MC, Hoeng J. A lung/liver-on-a-chip platform for acute and chronic toxicity studies. Lab Chip. 2018;18(24):3814–3829. doi:10.1039/c8lc01029c.
   PubMed Web of Science ®Google Scholar
• Rogal J, Probst C, Loskill P. Integration concepts for multi-organ chips: how to maintain flexibility?! Futur Sci OA. 2017;3(2):180. doi:10.4155/FSOA-2016-0092.
   Google Scholar
• Oliveira JM, Reis RL. eds. Biomaterials- and microfluidics-based tissue engineered 3D models. Vol 1230. 1st. Springer International Publishing; 2020. 10.1007/978-3-030-36588-2
   Google Scholar
• Tsamandouras N, Chen WLK, Edington CD, Stokes CL, Griffith LG, Cirit M. Integrated gut and liver microphysiological systems for quantitative in vitro pharmacokinetic studies. AAPS J. 2017;19(5):1499–1512. doi:10.1208/s12248-017-0122-4.
   PubMed Web of Science ®Google Scholar
• Marin TM, de Carvalho Indolfo N, Rocco SA, Basei FL, de Carvalho M, de Almeida Gonçalves K, Pagani E. Acetaminophen absorption and metabolism in an intestine/liver microphysiological system. Chem Biol Interact. 2019;299:59–76. doi:10.1016/J.CBI.2018.11.010.
   PubMed Web of Science ®Google Scholar
• Milani N, Parrott N, Franyuti DO, Godoy P, Galetin A, Gertz M, Fowler S. Application of a gut–liver-on-a-chip device and mechanistic modelling to the quantitative in vitro pharmacokinetic study of mycophenolate mofetil. Lab Chip. 2022;22(15):2853–2868. doi:10.1039/D2LC00276K.
   PubMed Web of Science ®Google Scholar
• Mahler GJ, Esch MB, Glahn RP, Shuler ML. Characterization of a gastrointestinal tract microscale cell culture analog used to predict drug toxicity. Biotechnol Bioeng. 2009;104(1):193–205. doi:10.1002/BIT.22366.
   PubMed Web of Science ®Google Scholar
• Hawkins KG, Casolaro C, Brown JA, Edwards DA, Wikswo JP. The microbiome and the gut-liver-brain axis for central nervous system clinical pharmacology: challenges in specifying and integrating in vitro and in silico models. Clin Pharmacol Ther. 2020;108(5):929–948. doi:10.1002/CPT.1870.
   PubMed Web of Science ®Google Scholar
• Lee DW, Ha SK, Choi I, Sung JH. 3D gut-liver chip with a PK model for prediction of first-pass metabolism. Biomed Microdevices. 2017;19(4):100. doi:10.1007/S10544-017-0242-8.
   PubMed Web of Science ®Google Scholar
• Zu Bentrup K H, Ramamurthy R, Ott CM, Emami K, Nelman-Gonzalez M, Wilson JW, Richter EG, Goodwin TJ, Alexander JS, Pierson DL, et al. Three-dimensional organotypic models of human colonic epithelium to study the early stages of enteric salmonellosis. Microbes Infect. 2006;8(7):1813–1825. doi:10.1016/j.micinf.2006.02.020.
   PubMed Web of Science ®Google Scholar
• Aisenbrey EA, Murphy WL. Synthetic alternatives to Matrigel. Nat Rev Mater . 2020;5(7):539–551. doi:10.1038/s41578-020-0199-8.
   PubMed Web of Science ®Google Scholar
• Evans JM, Morris LS, Marchesi JR. The gut microbiome: the role of a virtual organ in the endocrinology of the host. J Endocrinol. 2013;218(3):37–47. doi:10.1530/JOE-13-0131.
   Web of Science ®Google Scholar
• Boeri L, Izzo L, Sardelli L, Tunesi M, Albani D, Giordano C. Advanced organ-on-a-chip devices to investigate liver multi-organ communication: focus on gut, microbiota and brain. Bioengineering. 2019;6(4):91. doi:10.3390/BIOENGINEERING6040091.
   PubMedGoogle Scholar
• Li H, He J, Jia W. The influence of gut microbiota on drug metabolism and toxicity. Expert Opin Drug Metab Toxicol. 2016;12(1):31–40. doi:10.1517/17425255.2016.1121234.
   PubMed Web of Science ®Google Scholar
• Walsh J, Griffin BT, Clarke G, Hyland NP. Drug–gut microbiota interactions: implications for neuropharmacology. Br J Pharmacol. 2018;175(24):4429. doi:10.1111/BPH.14366.
   Web of Science ®Google Scholar
• Green CJ, Charlton CA, Wang LM, Silva M, Morten KJ, Hodson L. The isolation of primary hepatocytes from human tissue: optimising the use of small non-encapsulated liver resection surplus. Cell Tissue Bank. 2017;18(4):597–604. doi:10.1007/S10561-017-9641-6.
   PubMed Web of Science ®Google Scholar
• Ma X, Qu X, Zhu W, Li Y-S, Yuan S, Zhang H, Liu J, Wang P, Lai CSE, Zanella F, et al. Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting. Proc Natl Acad Sci U S A. 2016;113(8):2206–2211. doi:10.1073/pnas.1524510113.
   PubMed Web of Science ®Google Scholar
• Lee H, Chae S, Kim JY, Han W, Kim J, Choi Y, Cho D-W. Cell-printed 3D liver-on-a-chip possessing a liver microenvironment and biliary system. Biofabrication. 2019;11(2):025001. doi:10.1088/1758-5090/aaf9fa.
   PubMed Web of Science ®Google Scholar
• Kim W, Kim G. Intestinal villi model with blood capillaries fabricated using collagen-based bioink and dual-cell-printing process. ACS Appl Mater Interfaces. 2018;10(48):41185–41196. doi:10.1021/ACSAMI.8B17410.
   PubMed Web of Science ®Google Scholar
• Brassard JA, Nikolaev M, Hübscher T, Hofer M, Lutolf MP. Recapitulating macro-scale tissue self-organization through organoid bioprinting. Nat Mater. 2020;20(1):22–29. doi:10.1038/s41563-020-00803-5.
   PubMed Web of Science ®Google Scholar
• Kim WJ, Kim GH. An intestinal model with a finger-like villus structure fabricated using a bioprinting process and collagen/SIS-based cell-laden bioink. Theranostics. 2020;10(6):2495–2508. doi:10.7150/THNO.41225.
   PubMed Web of Science ®Google Scholar
• Ma X, Liu J, Zhu W, Tang M, Lawrence N, Yu C, Gou M, Chen S. 3D bioprinting of functional tissue models for personalized drug screening and in vitro disease modeling. Adv Drug Deliv Rev. 2018;132:235–251. doi:10.1016/j.addr.2018.06.011.
   PubMed Web of Science ®Google Scholar
• Rothbauer M, Eilenberger C, Spitz S, Bachmann BEM, Kratz SRA, Reihs EI, Windhager R, Toegel S, Ertl P. Recent advances in additive manufacturing and 3d bioprinting for organs-on-a-chip and microphysiological systems. Front Bioeng Biotechnol. 2022;10:837087. doi:10.3389/FBIOE.2022.837087.
   PubMed Web of Science ®Google Scholar
• Chang R, Nam J, Sun W. Direct cell writing of 3D microorgan for in vitro pharmacokinetic model. Tissue Eng - Part C Methods. 2008;14(2):157–166. doi:10.1089/ten.tec.2007.0392.
   PubMed Web of Science ®Google Scholar
• Massa S, Sakr MA, Seo J, Bandaru P, Arneri A, Bersini S, Zare-Eelanjegh E, Jalilian E, Cha B-H, Antona S, et al. Bioprinted 3D vascularized tissue model for drug toxicity analysis. Biomicrofluidics. 2017;11(4):044109. doi:10.1063/1.4994708.
   PubMed Web of Science ®Google Scholar
• Lim SH, Kathuria H, Tan JJY, Kang L. 3D printed drug delivery and testing systems — a passing fad or the future? Adv Drug Deliv Rev. 2018;132:139–168. doi:10.1016/j.addr.2018.05.006.
   PubMed Web of Science ®Google Scholar
• Wu JJ, Huang LM, Zhao Q, Xie T. 4D printing: history and recent progress. Chinese J Polym Sci. 2018;36(5):563–575. doi:10.1007/s10118-018-2089-8.
   Web of Science ®Google Scholar
• van Meer BJ, de Vries H, Firth KSA, van Weerd J, Tertoolen LGJ, Karperien HBJ, Jonkheijm P, Denning C, IJzerman AP, Mummery CL, et al. Small molecule absorption by PDMS in the context of drug response bioassays. Biochem Biophys Res Commun. 2017;482(2):323–328. doi:10.1016/j.bbrc.2016.11.062.
   PubMed Web of Science ®Google Scholar
• Sarkar U, Rivera-Burgos D, Large EM, Hughes DJ, Ravindra KC, Dyer RL, Ebrahimkhani MR, Wishnok JS, Griffith LG, Tannenbaum SR, et al. Metabolite profiling and pharmacokinetic evaluation of hydrocortisone in a perfused three-dimensional human liver bioreactor. Drug Metab Dispos. 2015;43(7):1091–1099. doi:10.1124/dmd.115.063495.
   PubMed Web of Science ®Google Scholar
• Halldorsson S, Lucumi E, Gómez-Sjöberg R, Fleming RMT. Advantages and challenges of microfluidic cell culture in polydimethylsiloxane devices. Biosens Bioelectron. 2015;63:218–231. doi:10.1016/j.bios.2014.07.029.
   PubMed Web of Science ®Google Scholar
• Oliveira M, Conceição P, Kant K, Ainla A, Diéguez L. Electrochemical sensing in 3d cell culture models: new tools for developing better cancer diagnostics and treatments. Cancers (Basel). 2021;13(6):1381. doi:10.3390/cancers13061381.
   PubMed Web of Science ®Google Scholar
• 2030 agenda - global compact. Accessed June 8, 2022. https://globalcompact.pt/index.php/en/2030-agenda
   Google Scholar
• Dekker S, Buesink W, Blom M, Alessio M, Verplanck N, Hihoud M, Dehan C, César W, Le Nel A, van den Berg A, et al. Standardized and modular microfluidic platform for fast lab on chip system development. Sensors Actuators B Chem. 2018;272:468–478. doi:10.1016/J.SNB.2018.04.005.
   Web of Science ®Google Scholar
• Cong H, Zhang N. Perspectives in translating microfluidic devices from laboratory prototyping into scale-up production. Biomicrofluidics. 2022;16(2):021301. doi:10.1063/5.0079045.
   PubMed Web of Science ®Google Scholar
• Mansouri M, Ahmed A, Ahmad SD, McCloskey MC, Joshi IM, Gaborski TR, Waugh RE, McGrath JL, Day SW, Abhyankar VV, et al. The modular µSiM reconfigured: integration of microfluidic capabilities to study in vitro barrier tissue models under flow. Adv Healthc Mater. 2022;11(21):2200802. doi:10.1002/ADHM.202200802.
   Web of Science ®Google Scholar
• Volpatti LR, Yetisen AK. Commercialization of microfluidic devices. Trends Biotechnol. 2014;32(7):347–350. doi:10.1016/J.TIBTECH.2014.04.010.
   PubMed Web of Science ®Google Scholar
• Liu X, Su Q, Zhang X, Yang W, Ning J, Jia K, Xin J, Li H, Yu L, Liao Y, et al. Recent advances of organ-on-a-chip in cancer modeling research. Biosensors. 2022;12(11):1045. doi:10.3390/BIOS12111045.
   PubMedGoogle Scholar
• Paguirigan AL, Beebe DJ. Microfluidics meet cell biology: bridging the gap by validation and application of microscale techniques for cell biological assays. BioEssays. 2008;30(9):811–821. doi:10.1002/BIES.20804.
   PubMed Web of Science ®Google Scholar
• Piergiovanni M, Leite SB, Corvi R, Whelan M. Standardisation needs for organ on chip devices. Lab Chip. 2021;21(15):2857–2868. doi:10.1039/D1LC00241D.
   PubMed Web of Science ®Google Scholar
• Frey N, Sönmez UM, Minden J, LeDuc P. Microfluidics for understanding model organisms. Nat Commun. 2022;13(1):3195. doi:10.1038/s41467-022-30814-6.
   PubMed Web of Science ®Google Scholar
• Chiu DT, Demello AJ, Di CD, Doyle PS, Hansen C, Maceiczyk RM, Wootton RCR. Small but perfectly formed? Successes, challenges, and opportunities for microfluidics in the chemical and biological sciences. Chem. 2017;2(2):201–223. doi:10.1016/j.chempr.2017.01.009.
   Web of Science ®Google Scholar
• Chen X, Mo D, Gong M. 3D printed reconfigurable modular microfluidic system for generating gel microspheres. Micromachines. 2020;11(2):1–9. doi:10.3390/MI11020224.
   Web of Science ®Google Scholar
• Gardiner LJ, Carrieri AP, Wilshaw J, Checkley S, Pyzer-Knapp EO, Krishna R. Using human in vitro transcriptome analysis to build trustworthy machine learning models for prediction of animal drug toxicity. Sci Rep. 2020;10(1):9522. doi:10.1038/s41598-020-66481-0.
   PubMed Web of Science ®Google Scholar
• Lysenko A, Sharma A, Boroevich KA, Tsunoda T. An integrative machine learning approach for prediction of toxicity-related drug safety. Life Sci Alliance. 2018;1(6):e201800098. doi:10.26508/lsa.201800098.
   PubMed Web of Science ®Google Scholar
• Zhang H, Mao J, Qi H-Z, Ding L. In silico prediction of drug-induced developmental toxicity by using machine learning approaches. Mol Divers. 2020;24(4):1281–1290. doi:10.1007/s11030-019-09991-y.
   PubMed Web of Science ®Google Scholar
• Hammann F, Schöning V, Drewe J. Prediction of clinically relevant drug-induced liver injury from structure using machine learning. J Appl Toxicol. 2019;39(3):412–419. doi:10.1002/jat.3741.
   PubMed Web of Science ®Google Scholar
• Su R, Wu H, Liu X, Wei L. Predicting drug-induced hepatotoxicity based on biological feature maps and diverse classification strategies. Brief Bioinform. 2021;22(1):428–437. doi:10.1093/bib/bbz165.
   PubMed Web of Science ®Google Scholar
• Yang H, Sun L, Li W, Liu G, Tang Y. In silico prediction of chemical toxicity for drug design using machine learning methods and structural alerts. Front Chem. 2018;6:30. doi:10.3389/fchem.2018.00030.
   PubMed Web of Science ®Google Scholar
• Klak M, Bryniarski T, Kowalska P, Gomolka M, Tymicki G, Kosowska K, Cywoniuk P, Dobrzanski T, Turowski P, Wszola M, et al. Novel strategies in artificial organ development: what is the future of medicine? Micromachines. 2020;11(7):646. doi:10.3390/MI11070646.
   PubMed Web of Science ®Google Scholar
• Ingber DE. Developmentally inspired human “organs on chips. Development. 2018;145(16):dev156125. doi:10.1242/DEV.156125.
   PubMed Web of Science ®Google Scholar
• Rubiano A, Indapurkar A, Yokosawa R, Miedzik A, Rosenzweig B, Arefin A, Moulin CM, Dame K, Hartman N, Volpe DA, et al. Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation. Clin Transl Sci. 2021;14(3):1049–1061. doi:10.1111/CTS.12969.
   PubMed Web of Science ®Google Scholar
• Schweinlin M, Wilhelm S, Schwedhelm I, Hansmann J, Rietscher R, Jurowich C, Walles H, Metzger M. Development of an advanced primary human in vitro model of the small intestine. Tissue Eng Part C Methods. 2016;22(9):873–883. doi:10.1089/TEN.TEC.2016.0101.
   PubMed Web of Science ®Google Scholar